I too have been following the upcoming approval of brensocatib very closely. It provided a glimmer of hope for those of us with bronchiectasis. It seems that the expedited approval may have been axed, since the drug approvals office has been put on the chopping block by the current administration. The article below is dated February 24. Does anyone have any further information on this?
https://www.prnewswire.com/news-releases/insmed-announces-that-fda-does-not-currently-plan-to-hold-advisory-committee-meeting-to-discuss-new-drug-application-for-brensocatib-in-patients-with-bronchiectasis-302382854.html